{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:57:24Z","timestamp":1787644644517,"version":"build-2736575974"},"reference-count":45,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dysregulation of T-cell\u2013mediated immunity is responsible for acquired pure red cell aplasia (PRCA). Although STAT3 mutations are frequently detected in patients with T-cell large granular lymphocytic leukemia (T-LGLL), which is often complicated by PRCA and which is also reported to be associated with acquired aplastic anemia (AA) and myelodysplastic syndrome (MDS), whether STAT3-mutated T cells are involved in the pathophysiology of PRCA and other types of bone marrow failure remains unknown. We performed STAT3 mutation analyses of the peripheral blood mononuclear cells from PRCA patients (n = 42), AA (n = 54), AA\u2013paroxysmal nocturnal hemoglobinuria (AA-PNH; n = 7), and MDS (n = 21) using an allele-specific polymerase chain reaction and amplicon sequencing. STAT3 mutations were not detected in any of the 82 patients with AA\/PNH\/MDS but were detected in 43% of the 42 PRCA patients. In all 7 STAT3-mutation\u2013positive patients who were studied, the STAT3 mutations were restricted to sorted CD8+ T cells. The prevalence of STAT3 mutation in idiopathic, thymoma-associated, autoimmune disorder\u2013associated, and T-LGLL\u2013associated PRCA was 33% (5 of 15), 29% (2 of 7), 20% (1 of 5), and 77% (10 of 13), respectively. The STAT3-mutation\u2013positive patients were younger (median age, 63 vs 73 years; P= .026) and less responsive to cyclosporine (46% [6 of 13] vs 100% [8 of 8]; P= .0092) in comparison with STAT3-mutation\u2013negative patients. The data suggest that STAT3-mutated CD8+ T cells may be closely involved in the selective inhibition of erythroid progenitors in PRCA patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018022723","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T13:25:19Z","timestamp":1539869119000},"page":"2704-2712","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-5332","authenticated-orcid":false,"given":"Toru","family":"Kawakami","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nodoka","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, School of Medicine,"},{"name":"Department of Comprehensive Cancer Therapy, School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Health and Medical Sciences, Graduate School of Medicine, Shinshu University, Matsumoto, Japan;"},{"name":"Department of Laboratory Medicine, Nagano Children\u2019s Hospital, Azumino, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Imi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medical Science, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4056-7242","authenticated-orcid":false,"given":"Kazuyuki","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Central Laboratory Department, Shinshu University Hospital, Matsumoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Yamane","sequence":"additional","affiliation":[{"name":"Department of Biomedical Laboratory Sciences, School of Medicine, Shinshu University, Matsumoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Nishina","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Senoo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Hematology, Matsumoto Medical Center, Masumoto Hospital, Matsumoto, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5182-0960","authenticated-orcid":false,"given":"Tomonobu","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Cancer Therapy, School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hirokawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Clinical Laboratory Medicine, Graduate School of Medicine, Akita University, Akita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medical Science, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, School of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, School of Medicine,"},{"name":"Department of Health and Medical Sciences, Graduate School of Medicine, Shinshu University, Matsumoto, Japan;"},{"name":"Department of Biomedical Laboratory Sciences, School of Medicine, Shinshu University, Matsumoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"issue":"20","key":"2020021108382297100_B1","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"2020021108382297100_B2","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020021108382297100_B3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"2020021108382297100_B4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020021108382297100_B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","article-title":"Clonal diseases of large granular lymphocytes","volume":"82","author":"Loughran","year":"1993","journal-title":"Blood"},{"issue":"14","key":"2020021108382297100_B6","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2020021108382297100_B7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.leukres.2012.02.001","article-title":"Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study","volume":"36","author":"Nyland","year":"2012","journal-title":"Leuk Res"},{"issue":"10","key":"2020021108382297100_B8","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1182\/blood.V96.10.3644","article-title":"Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia","volume":"96","author":"Go","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2020021108382297100_B9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2141.2001.02561.x","article-title":"Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features","volume":"112","author":"Saunthararajah","year":"2001","journal-title":"Br J Haematol"},{"issue":"3","key":"2020021108382297100_B10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cas.12341","article-title":"STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia","volume":"105","author":"Ishida","year":"2014","journal-title":"Cancer Sci"},{"issue":"21","key":"2020021108382297100_B11","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood-2017-11-764357","article-title":"Novel insights into the pathogenesis of T-cell lymphomas","volume":"131","author":"Van Arnam","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020021108382297100_B12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1756-8722-6-82","article-title":"STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia","volume":"6","author":"Qiu","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"21","key":"2020021108382297100_B13","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure red cell aplasia","volume":"128","author":"Means","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2020021108382297100_B14","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2020021108382297100_B15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4081\/hr.2010.e1","article-title":"Immune dysregulation in myelodysplastic syndrome","volume":"2","author":"Sugimori","year":"2010","journal-title":"Hematol Rep"},{"key":"2020021108382297100_B16","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed."},{"issue":"1","key":"2020021108382297100_B17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","article-title":"The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis","volume":"89","author":"Semenzato","year":"1997","journal-title":"Blood"},{"issue":"10","key":"2020021108382297100_B18","first-page":"1922","article-title":"Diagnosis and management of pure red cell aplasia [in Japanese]","volume":"56","author":"Hirokawa","year":"2015","journal-title":"Rinsho Ketsueki"},{"issue":"2","key":"2020021108382297100_B19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"2020021108382297100_B20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0609.2004.00348.x","article-title":"Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia","volume":"73","author":"Casadevall","year":"2004","journal-title":"Eur J Haematol"},{"issue":"10","key":"2020021108382297100_B21","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","article-title":"How I treat LGL leukemia","volume":"117","author":"Lamy","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2020021108382297100_B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group","volume":"93","author":"Hirokawa","year":"2008","journal-title":"Haematologica"},{"issue":"12","key":"2020021108382297100_B23","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"2020021108382297100_B24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2020021108382297100_B25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3324\/haematol.2017.175810","article-title":"Rational management approach to pure red cell aplasia","volume":"103","author":"Balasubramanian","year":"2018","journal-title":"Haematologica"},{"key":"2020021108382297100_B26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2017.12.014","article-title":"STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia","volume":"73","author":"Shi","year":"2018","journal-title":"Hum Pathol"},{"issue":"10","key":"2020021108382297100_B27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.12871","article-title":"Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group","volume":"93","author":"Fujishima","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"2020021108382297100_B28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00277-009-0895-3","article-title":"T-cell large granular lymphocyte leukemia: an Asian perspective","volume":"89","author":"Kwong","year":"2010","journal-title":"Ann Hematol"},{"issue":"6","key":"2020021108382297100_B29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12185-015-1787-z","article-title":"The diagnosis and treatment of aplastic anemia: a review","volume":"101","author":"Miano","year":"2015","journal-title":"Int J Hematol"},{"issue":"1","key":"2020021108382297100_B30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"2020021108382297100_B31","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1073\/pnas.1700682114","article-title":"Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1\/STAT3 mutations","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020021108382297100_B32","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"2020021108382297100_B33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"2020021108382297100_B34","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/leu.2015.263","article-title":"Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia","volume":"30","author":"Andersson","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"2020021108382297100_B35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2020021108382297100_B36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"issue":"16","key":"2020021108382297100_B37","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"issue":"7157","key":"2020021108382297100_B38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"issue":"4","key":"2020021108382297100_B39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma [published correction appears in Cancer Cell. 2015;27(5):744]","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"issue":"6","key":"2020021108382297100_B40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/bjh.14487","article-title":"STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in mice","volume":"180","author":"Dutta","year":"2018","journal-title":"Br J Haematol"},{"issue":"11","key":"2020021108382297100_B41","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3324\/haematol.2013.085068","article-title":"STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model","volume":"98","author":"Couronn\u00e9","year":"2013","journal-title":"Haematologica"},{"key":"2020021108382297100_B42","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1038\/ncomms15869","article-title":"Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis","volume":"8","author":"Savola","year":"2017","journal-title":"Nat Commun"},{"key":"2020021108382297100_B43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2016.11.018","article-title":"A novel class of somatic mutations in blood detected preferentially in CD8+ cells","volume":"175","author":"Valori","year":"2017","journal-title":"Clin Immunol"},{"issue":"1","key":"2020021108382297100_B44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2020021108382297100_B45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","article-title":"Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience","volume":"135","author":"Thompson","year":"2006","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/20\/2704\/1629590\/advances022723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/20\/2704\/1629590\/advances022723.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T11:34:02Z","timestamp":1605267242000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/20\/2704\/16114\/Frequent-STAT3-mutations-in-CD8-T-cells-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":45,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018,10,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018022723","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]}}}